-+ 0.00%
-+ 0.00%
-+ 0.00%

*Sangamo Therapeutics Sees Cash and Cash Equivalents, Offering Proceeds Funding Planned Ops Into 3Q >SGMO

Dow Jones·03/30/2026 20:10:00

Please log in to view news